Melissa Adams: Daily

A landmark judicial pact with Singapore will help Vietnam build a new international commercial court, a strategic move to attract global capital and reshape trade.

Beyond the headlines of multi-million dollar settlements lies a complex formula. What truly determines what an injury claim is worth? We break it down.

Great Canadian's sale of its flagship BC casino to a First Nations partnership marks a major shift, channeling profits into communities and reshaping the industry.

The latest AI benchmarks are in, revealing a seismic shift. It's not just about speed; it's about efficiency, access, and a whole new model architecture.

The U.S. life/annuity industry’s Q1 income fell by double digits, yet net profits jumped 16%. We dissect the financial engineering behind this paradox.

The legendary wellness brand's new Austin resort isn't just a luxury getaway; it's a blueprint for integrated living, blending a hotel, homes, and a medical center.

A new project management tool offers unlimited users for just $15.99/month, challenging giants like Asana. But can this radical model actually work?

The new 'BB-' rating for EquipmentShare is more than a financial milestone. It's a validation of how its T3 tech platform is building a new giant.

A new report shows Canada's Grocery Code has industry support, but deep-seated fear prevents suppliers from using it to challenge powerful retailers.

A key agreement for a Halifax solar farm moves Nova Scotia closer to its green goals, offering renters and businesses a stake in the clean energy economy.

Onix launches its Wingspan platform in Europe, introducing proprietary 'Semantic Twin' technology to help regulated industries navigate the EU's strict AI compliance maze.

A landmark deal between Cambridge and Australia's UAC gives A-Level students a direct ATAR pathway, signaling a major shift in university admissions.

Light AI's smartphone diagnostic tool enters a crucial New Zealand study, but can its innovative tech overcome financial pressures and regulatory hurdles?

A new "barcode scam" is fueling a surge in losses for utility customers. PG&E reports a grim trend, but this is a nationwide problem. Here's the playbook.

Beyond the perfect steak, a new model for business success emerges, blending operational mastery with the strategic art of 'edvertising.' A deep dive.

VisionWave files a patent for a powerful new AI brain. Is SDNN™ a revolution in autonomous defense or a speculative bet on a digital future?

As 250 million people await a drug for lymphatic diseases, Celltaxis appoints a new CEO to drive its promising inflammation-targeting therapy toward the finish line.

Northern Trust's new Dublin banking license is more than expansion; it's a calculated response to strict new EU regulations and a major win for Ireland.

Aussie biotech ENA Respiratory secures crucial US patents for its novel immune modulator, signaling a major strategic move in the multi-billion dollar fight against COPD.

A Dutch biotech is in late-stage trials for nizubaglustat, a drug targeting rare, fatal neurological disorders. A look at the science, strategy, and hope.